Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Gastroenterology
Systemic lupus erythematosus
Questions discussed in this category
What is your approach to pharmacologic treatment options in a patient with both SLE and Crohn's disease?
A female in her 50s with iatrogenic Cushing's Syndrome presenting for management of SLE with low disease activity (but not remission) in the setting o...
1 Answer available
16438
Papers discussed in this category
Arthritis Rheumatol, 2020 Apr 01
Maintenance of Efficacy and Safety of Ustekinumab Through One Year in a Phase II Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Patients With Active Systemic Lupus Erythematosus.
Ann Rheum Dis, 2022 Jul 07
Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus.
Related Topics in Gastroenterology
Rheumatology
General Rheumatology
Hematology
Medical Oncology
Nutrition
Neuromuscular
Neurology
Benign Hematology
Infectious Disease
Endocrinology